Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATRC AtriCure	$31.78 +1.2%	$32.50	$20.20 ▼ $43.11	$1.57B	1.56	605,921 shs	166,072 shs
GKOS Glaukos	$103.50 -0.1%	$95.71	$77.10 ▼ $163.71	$5.91B	0.82	739,359 shs	289,937 shs
INSP Inspire Medical Systems	$128.39 -1.8%	$142.27	$123.00 ▼ $225.00	$3.79B	1.25	551,519 shs	301,417 shs
IRTC iRhythm Technologies	$142.37 -0.3%	$139.98	$55.92 ▼ $157.13	$4.54B	1.41	482,173 shs	206,877 shs
MMSI Merit Medical Systems	$93.56 +0.0%	$94.77	$82.62 ▼ $111.45	$5.53B	0.65	536,816 shs	151,957 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATRC AtriCure	+1.24%	-3.35%	-8.49%	+1.50%	+41.56%
GKOS Glaukos	-0.17%	+2.25%	+9.45%	+23.77%	-13.12%
INSP Inspire Medical Systems	-1.71%	-1.23%	-7.25%	-9.26%	-4.03%
IRTC iRhythm Technologies	-0.29%	-6.76%	-1.80%	+41.88%	+47.13%
MMSI Merit Medical Systems	+0.05%	+0.81%	-1.10%	+1.14%	+8.97%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATRC AtriCure	3.3351 of 5 stars	3.5	5.0	0.0	1.4	2.5	0.6
GKOS Glaukos	4.453 of 5 stars	4.4	1.0	4.4	2.7	1.7	0.6
INSP Inspire Medical Systems	4.8552 of 5 stars	4.4	1.0	4.8	3.3	2.5	1.9
IRTC iRhythm Technologies	1.2147 of 5 stars	2.5	1.0	0.0	2.6	0.8	0.6
MMSI Merit Medical Systems	4.3697 of 5 stars	3.4	2.0	3.8	2.4	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATRC AtriCure	3.00	Buy	$50.67	59.43% Upside
GKOS Glaukos	2.75	Moderate Buy	$134.67	30.11% Upside
INSP Inspire Medical Systems	2.73	Moderate Buy	$211.91	65.06% Upside
IRTC iRhythm Technologies	2.90	Moderate Buy	$138.60	-2.64% Downside
MMSI Merit Medical Systems	2.89	Moderate Buy	$109.11	16.63% Upside

Current Analyst Ratings Breakdown

Latest MMSI, IRTC, GKOS, INSP, and ATRC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/11/2025	IRTC iRhythm Technologies	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$130.00 ➝ $160.00
5/23/2025	MMSI Merit Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $110.00
5/22/2025	IRTC iRhythm Technologies	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$130.00 ➝ $167.00
5/21/2025	MMSI Merit Medical Systems	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$108.00 ➝ $112.00
5/21/2025	MMSI Merit Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $108.00
5/15/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$100.00 ➝ $108.00
5/6/2025	GKOS Glaukos	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$110.00 ➝ $72.00
5/6/2025	INSP Inspire Medical Systems	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$220.00 ➝ $200.00
5/6/2025	INSP Inspire Medical Systems	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$235.00 ➝ $195.00
5/6/2025	INSP Inspire Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$195.00 ➝ $174.00
5/6/2025	INSP Inspire Medical Systems	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$230.00 ➝ $236.00

(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATRC AtriCure	$480.08M	3.28	N/A	N/A	$9.46 per share	3.36
GKOS Glaukos	$383.48M	15.42	N/A	N/A	$13.91 per share	7.44
INSP Inspire Medical Systems	$802.80M	4.72	$1.68 per share	76.51	$23.01 per share	5.58
IRTC iRhythm Technologies	$591.84M	7.68	N/A	N/A	$2.90 per share	49.09
MMSI Merit Medical Systems	$1.36B	4.08	$5.61 per share	16.68	$23.67 per share	3.95

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATRC AtriCure	-$44.70M	-$0.81	N/A	N/A	N/A	-7.95%	-5.68%	-4.34%	7/29/2025 (Estimated)
GKOS Glaukos	-$146.37M	-$2.37	N/A	N/A	N/A	-31.40%	-10.66%	-8.06%	7/30/2025 (Estimated)
INSP Inspire Medical Systems	$53.51M	$2.17	59.16	39.87	2.00	7.92%	10.00%	8.68%	8/5/2025 (Estimated)
IRTC iRhythm Technologies	-$113.29M	-$3.14	N/A	N/A	N/A	-15.90%	-101.04%	-9.55%	7/30/2025 (Estimated)
MMSI Merit Medical Systems	$120.36M	$2.04	45.86	24.95	3.08	8.81%	15.52%	8.72%	7/30/2025 (Estimated)

Latest MMSI, IRTC, GKOS, INSP, and ATRC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	GKOS Glaukos	-$0.26	N/A	N/A	N/A	$115.49 million	N/A
7/29/2025	Q2 2025	ATRC AtriCure	-$0.15	N/A	N/A	N/A	$130.17 million	N/A
5/5/2025	Q1 2025	INSP Inspire Medical Systems	-$0.23	$0.10	+$0.33	$0.10	$194.89 million	$201.32 million
5/1/2025	Q1 2025	IRTC iRhythm Technologies	-$0.89	-$0.95	-$0.06	-$0.97	$153.39 million	$158.68 million
4/30/2025	Q1 2025	GKOS Glaukos	-$0.33	-$0.22	+$0.11	-$0.32	$102.78 million	$106.66 million
4/29/2025	Q1 2025	ATRC AtriCure	-$0.25	-$0.14	+$0.11	-$0.14	$122.92 million	$123.62 million
4/24/2025	Q1 2025	MMSI Merit Medical Systems	$0.75	$0.86	+$0.11	$0.49	$352.57 million	$355.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATRC AtriCure	N/A	N/A	N/A	N/A	N/A
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATRC AtriCure	0.16	4.11	2.88
GKOS Glaukos	0.09	6.49	5.62
INSP Inspire Medical Systems	N/A	9.01	7.44
IRTC iRhythm Technologies	7.47	5.71	5.58
MMSI Merit Medical Systems	0.51	4.87	3.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATRC AtriCure	99.11%
GKOS Glaukos	99.04%
INSP Inspire Medical Systems	94.91%
IRTC iRhythm Technologies	N/A
MMSI Merit Medical Systems	99.66%

Insider Ownership

Company	Insider Ownership
ATRC AtriCure	3.50%
GKOS Glaukos	5.80%
INSP Inspire Medical Systems	4.10%
IRTC iRhythm Technologies	1.10%
MMSI Merit Medical Systems	3.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATRC AtriCure	1,050	49.51 million	47.77 million	Optionable
GKOS Glaukos	780	57.14 million	53.83 million	Optionable
INSP Inspire Medical Systems	1,246	29.49 million	28.29 million	Optionable
IRTC iRhythm Technologies	2,000	31.92 million	31.57 million	Optionable
MMSI Merit Medical Systems	7,400	59.10 million	57.21 million	Optionable

MMSI, IRTC, GKOS, INSP, and ATRC Headlines

Recent News About These Companies

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Recommendation of "Moderate Buy" by Brokerages

July 4 at 2:56 AM | marketbeat.com

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

July 3 at 5:13 PM | gurufocus.com

Merit Medical Systems Inc (MMSI) Announces Upcoming Financial Results Release and Investor Call ...

July 3 at 5:13 PM | gurufocus.com

Merit Medical Systems, Inc. to Release Q2 2025 Financial Results and Host Investor Conference Call on July 30

July 3 at 4:48 PM | quiverquant.comQ

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025 | MMSI Stock News

July 3 at 4:23 PM | gurufocus.com

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

July 3 at 4:16 PM | globenewswire.com

XRAY or MMSI: Which Is the Better Value Stock Right Now?

July 2 at 12:41 PM | zacks.com

34,130 Shares in Merit Medical Systems, Inc. (NASDAQ:MMSI) Bought by Lisanti Capital Growth LLC

June 29, 2025 | marketbeat.com

SG Americas Securities LLC Acquires Shares of 2,781 Merit Medical Systems, Inc. (NASDAQ:MMSI)

June 27, 2025 | marketbeat.com

MMSI Merit Medical Systems, Inc. - Seeking Alpha

June 25, 2025 | seekingalpha.com

Yorktown Management & Research Co Inc Makes New $312,000 Investment in Merit Medical Systems, Inc. (NASDAQ:MMSI)

June 24, 2025 | marketbeat.com

Merit Medical Systems’s Q1 Earnings Call: Our Top 5 Analyst Questions

June 23, 2025 | finance.yahoo.com

3 Reasons to Sell MMSI and 1 Stock to Buy Instead

June 23, 2025 | msn.com

Sowell Financial Services LLC Buys Shares of 4,108 Merit Medical Systems, Inc. (NASDAQ:MMSI)

June 21, 2025 | marketbeat.com

Hedge Fund and Insider Trading News: Kyle Bass, Warren Buffett, Coatue Management, Pentwater Capital Management, G-III Apparel Group Ltd (GIII), Merit Medical Systems Inc (MMSI), and More

June 20, 2025 | insidermonkey.com

Merit Medical Systems, Inc. (NASDAQ:MMSI) CFO Raul Jr. Parra Sells 15,181 Shares

June 17, 2025 | marketbeat.com

Conestoga Capital Advisors LLC Has $239.45 Million Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

June 17, 2025 | marketbeat.com

XRAY vs. MMSI: Which Stock Is the Better Value Option?

June 16, 2025 | zacks.com

70,069 Shares in Merit Medical Systems, Inc. (NASDAQ:MMSI) Acquired by Mountain Pacific Investment Advisers LLC

June 16, 2025 | marketbeat.com

Fred P. Lampropoulos Sells 400 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock

June 13, 2025 | insidertrades.com

Merit Medical Systems (NASDAQ:MMSI) Issues FY 2025 Earnings Guidance

June 13, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
330% Returns YTD: Is CoreWeave's Momentum Softening?
By Nathan Reiff | June 18, 2025
View 330% Returns YTD: Is CoreWeave's Momentum Softening?

MMSI, IRTC, GKOS, INSP, and ATRC Company Descriptions

AtriCure NASDAQ:ATRC

$31.78 +0.39 (+1.24%)

As of 07/3/2025 01:04 PM Eastern

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Glaukos NYSE:GKOS

$103.50 -0.13 (-0.13%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$103.42 -0.08 (-0.07%)

As of 07/3/2025 04:20 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Inspire Medical Systems NYSE:INSP

$128.38 -2.34 (-1.79%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$128.38 0.00 (0.00%)

As of 07/3/2025 04:56 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

iRhythm Technologies NASDAQ:IRTC

$142.36 -0.42 (-0.29%)

Closing price 07/3/2025 03:37 PM Eastern

Extended Trading

$142.36 0.00 (0.00%)

As of 07/3/2025 04:08 PM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Merit Medical Systems NASDAQ:MMSI

$93.56 +0.05 (+0.05%)

Closing price 07/3/2025 01:49 PM Eastern

Extended Trading

$93.56 0.00 (0.00%)

As of 07/3/2025 04:20 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time